Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/18287
Title: Can molecularly targeted therapy cure patients with resected EGFR mutant NSCLC?
Austin Authors: Klevansky, Myron ;John, Thomas 
Affiliation: Olivia Newton-John Cancer Wellness and Research Centre, Austin Health, Heidelberg, Victoria, Australia
Olivia Newton-John Cancer Research Institute, Heidelberg, Victoria, Australia
Issue Date: Jun-2018
Publication information: Journal of thoracic disease 2018; 10(Suppl 17): S1986-S1988
URI: https://ahro.austin.org.au/austinjspui/handle/1/18287
DOI: 10.21037/jtd.2018.04.156
Journal: Journal of thoracic disease
PubMed URL: 30023098
ISSN: 2072-1439
Type: Journal Article
Appears in Collections:Journal articles

Show full item record

Page view(s)

16
checked on May 30, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.